|
|
8054
|
CATAFLAM DROPS 1.5%
|
DICLOFENAC RESINATE
|
Novartis Pharma Services Inc
|
Withdrawn Voluntarily by MAH
|
Details →
|
|
|
H2007/17850/R1
|
Exforge tablets 10/160mg
|
Amlodipine/Valsartan
|
Novartis Pharma Services Inc
|
Retained
|
Details →
|
|
|
H2007/17849/R1
|
Exforge tablets 5/160mg
|
Amlodipine/valsartan
|
Novartis Pharma Services Inc
|
Retained
|
Details →
|
|
|
H2005/127/R1
|
Co-Diovan Tablets 160/12.5mg
|
Valsartan+Hydrochlorothiazide
|
Novartis Pharma Services Inc
|
Retained
|
Details →
|
|
|
16595
|
GLIVEC TABLETS 100MG
|
IMATINIB MESYLATE
|
Novartis Pharma Services Inc
|
Cancelled by PPB
|
Details →
|
|
|
17574
|
GLIVEC TABLETS 400MG
|
IMATINIB MESYLATE
|
Novartis Pharma Services Inc
|
Cancelled by PPB
|
Details →
|
|
|
H2011/7350
|
Cataflam 50mgTablets
|
Diclofenac Potassium
|
Novartis Pharma Services Inc
|
Retained
|
Details →
|
|
|
H2010/21679/541/R1
|
Galvusmet tablets 50/1000mg
|
Vildagliptin/metformin
|
Novartis Phrma Services Inc
|
Retained
|
Details →
|
|
|
H2010/21677/539/R1
|
Galvusmet tablets 50/500mg
|
vildagliptin+metformin
|
Novartis Pharma Services Inc
|
Retained
|
Details →
|
|
|
H2010/21679/540/R1
|
Galvusmet tablets 50/850mg
|
Vildagliptin/metformin
|
Novartis Pharma Services Inc
|
Retained
|
Details →
|
|
|
H2017/CTD4096/058/R1
|
Valsartan 80mg
|
Valsartan 80mg
|
Novartis Pharma Services Inc
|
Retained
|
Details →
|